OptimizeRx Corp (OPRX) › Operating Cash FlowOptimizeRx Corp (OPRX) — Operating Cash FlowAnnual figures by period end, from SEC filings.2010-12-31: -$1.31M2011-12-31: -$521.5K2012-12-31: -$624.0K2013-12-31: $1.13M2014-12-31: -$56.4K2015-12-31: $515.1K2016-12-31: -$466.0K2017-12-31: -$1.48M2018-12-31: $792.6K2019-12-31: -$1.66M2020-12-31: -$6.31M2021-12-31: $726.0K2022-12-31: $10.65M2023-12-31: -$7.24M2024-12-31: $4.89M2025-12-31: $18.71M$18.71M2010-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31$18.71M+282.8%2026-03-12From 2025-01-012024-12-31$4.89M—2026-03-12From 2024-01-012023-12-31-$7.24M-168.0%2025-03-20From 2023-01-012022-12-31$10.65M+1367.4%2024-04-15From 2022-01-012021-12-31$726.0K—2023-03-10From 2021-01-012020-12-31-$6.31M—2023-03-10From 2020-01-012019-12-31-$1.66M-309.5%2021-03-08From 2019-01-012018-12-31$792.6K—2020-03-26From 2018-01-012017-12-31-$1.48M—2019-03-12From 2017-01-012016-12-31-$466.0K-190.5%2018-03-08From 2016-01-012015-12-31$515.1K—2017-03-08From 2015-01-012014-12-31-$56.4K-105.0%2016-03-15From 2014-01-012013-12-31$1.13M—2015-09-16From 2013-01-012012-12-31-$624.0K—2014-03-31From 2012-01-012011-12-31-$521.5K—2013-03-12From 2011-01-012010-12-31-$1.31M—2012-03-30From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)